Promore Pharma AB (publ) Interim report January – March 2020

2020-05-26

Net sales amounted to MSEK 0.0 (0.5) MSEK

The operating loss for the period was 7.3 (-5.5) MSEK

Net loss was 7.0 MSEK (-5.5) MSEK, corresponding to a loss per share of SEK 0.19 (-0.27)

Cash flow from operating activities amounted to -15.0 (-4.4) MSEK

Cash and cash equivalents amounted to 45.9 (26.6) MSEK

Läs hela meddelandet på Promore Pharmas hemsida.